BioMedNewsBreaks – MetAlert Inc. (MLRT) Approaching Inflection Point of Its Growth Curve

Jan 24, 2023

MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring, is launching a suite of wearable companion products to its innovative SmartSole shoe insole units. “The patented GPS-enabled SmartSole is a non-intrusive tracking device designed to monitor the location of people with cognitive memory disorders such as Alzheimer’s Disease who tend to get lost or wander. The tech-designed insole may also be used by people at risk of kidnapping, such as children, government employees and select professionals. A next-generation shoe insole branded SmartSole plus incorporates biometric sensors paired with smart analytics to analyze the wearer’s movements for assessing overall health and wellness, and the company’s most recent product rollout – the in-home RoomMate system – uses 3D infrared motion-sensitive technology to allow caregivers to remotely monitor fall-prone loved ones in an unobtrusive manner,” a recent article reads. “MetAlert is approaching the inflection point of its growth curve by its ability to sell a multitude of products and services to a broader audience, which will result in greater revenue per user (‘RPU’),” MetAlert CEO Patrick Bertagna is quoted as saying.

To view the full article, visit https://ibn.fm/Gr9rl

About MetAlert Inc.

MetAlert is a pioneer in smart, mobile and wearable tracking and recovery location-based solutions, supported through a proprietary IOT enterprise monitoring platform and intellectual property portfolio. The company offers global end-to-end solutions of hardware, software and connectivity and develops two-way GPS tracking technologies, which seamlessly integrate with consumer products and enterprise applications, utilizing the latest in miniaturized, low power consumption GPS, cellular, RF, NFC, and BLE technology, enabling subscribers to track in real time the whereabouts of people or high value assets. MetAlert is known for its game-changing and award-winning patented GPS SmartSole – think Dr. Scholl’s meets LoJack, the world’s first visible wearable technology tracking device created for those at risk of wandering due to Alzheimer’s, dementia, autism and traumatic brain injury. MetAlert’s subscription based business model is built around technology innovation and the company holds dozens of patents, with many issued patents in the area of GPS tracking. The company has international distributors servicing customers across the globe with subscribers in over 40 countries and is a U.S. military government contractor. Other customers include public health authorities and municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes, and consumers. For more information, visit the company’s website at www.MetAlert.com.

NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork.

More News

In a Race With China, German Robots Are Outnumbered 14 to 1
Sep 24, 2026
In a Race With China, German Robots Are Outnumbered 14 to 1

A decade after the sale of Germany’s Kuka, Europe is seeking to shift into a higher gear to unlock the potential in robotics and artificial intelligence.

Tories would prevent long-term jobless spending benefits on alcohol and cigarettes
Sep 24, 2026
Tories would prevent long-term jobless spending benefits on alcohol and cigarettes

The proposals would also see benefits cut for people who are able to work but have failed to hold down a job.

Rolls-Royce signs 'multi-million' engine deal
Sep 24, 2026
Rolls-Royce signs 'multi-million' engine deal

The order will see 18 engines built and maintained by the company from its Derby aerospace centre.

What to think about when buying travel insurance
Sep 24, 2026
What to think about when buying travel insurance

Consumer expert Harry Kind walks through what to do when buying travel insurance.

Abortion Pills, Vaccines and Food Safety: F.D.A. Nominee Heidi Overton Faces Senate Confirmation Hearing
Sep 24, 2026
Abortion Pills, Vaccines and Food Safety: F.D.A. Nominee Heidi Overton Faces Senate Confirmation Hearing

Dr. Heidi Overton has called mifepristone “dangerous to women.” As a White House aide, she worked to reduce the number of vaccines recommended for children.

The ‘Monster’ Behind Russia’s Global Effort to Evade Western Sanctions
Sep 24, 2026
The ‘Monster’ Behind Russia’s Global Effort to Evade Western Sanctions

A Moscow firm uses shell companies and cryptocurrency to launder money, and a custom app to forge trade records, to help Russia bypass sweeping financial restrictions.

Europe's car makers are in crisis. Will the threat of war rescue them?
Sep 24, 2026
Europe's car makers are in crisis. Will the threat of war rescue them?

Auto executives across Europe hope rearmament can help them flex their industrial muscles once more.

Court Blocks Trump’s White House Ban on CNN, MS NOW and Politico
Sep 24, 2026
Court Blocks Trump’s White House Ban on CNN, MS NOW and Politico

Judge Timothy J. Kelly issued a temporary restraining order and told the White House to immediately restore the press credentials for the employees of the three news outlets.

Food banks 'in crisis' amid fears some may have to close
Sep 24, 2026
Food banks 'in crisis' amid fears some may have to close

According to the Trussell Trust, an anti-poverty charity, some food banks are having pay for 30-50% of the food they are supplying.

Rising fuel costs hitting businesses and customers
Sep 24, 2026
Rising fuel costs hitting businesses and customers

Business owners say higher fuel costs are creating challenges on several fronts.

Rise in 'commuter students' due to living costs
Sep 24, 2026
Rise in 'commuter students' due to living costs

Some young people are staying at home while attending university as they cannot afford to move.

Elizabeth Holmes to Transfer to Halfway House in August 2027
Sep 24, 2026
Elizabeth Holmes to Transfer to Halfway House in August 2027

The founder of the blood-testing start-up Theranos was sentenced to 11 years in prison for fraud and had been serving time at a minimum-security federal prison in Texas.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Manage The Numbers

Manage The Numbers is the world’s fastest-growing finance news website, featuring the latest money and market news, along with in-depth analysis so you can make the best decision.

Newsletter